Clinical Features, Outcomes, and Biology of EGFR exon 20 Insertions in a Cohort of Hispanic Patients with Non-small Cell Lung Cancer

被引：0
|
作者：
Motta, R. [1 ]
Cardona, A. [2 ]
Cruz, G. [3 ]
Aliaga, C. [1 ]
Carracedo, C. [1 ]
Raez, L. [4 ]
Arrieta, O. [3 ]
Mezquita, L. [5 ]
Albarran, V. [5 ]
Corrales, L. [6 ]
Bacon, L. [7 ]
Rojas, L.
Zuluaga, J.
Martin, C. [8 ]
Dabalsa, A. [4 ]
Ruiz-Patino, A. [9 ]
Freitas, H. [10 ]
Cordeiro, V. [10 ]
Failoc-Rojas, V. [1 ]
机构：
[1] ALIADA Canc Ctr, Lima, Peru
[2] Luis Carlos Sarmiento Angulo Canc Treatment & Res, Bogota, Colombia
[3] Inst Nacl Cancerol, Mexico City, DF, Mexico
[4] Mem Canc Inst, Hollywood, FL USA
[5] Hosp Clin Barcelona, Barcelona, Spain
[6] CIMCA, San Jose, Costa Rica
[7] Hosp Vivian Pellas, Managua, Nicaragua
[8] Alexander Fleming Inst, Buenos Aires, DF, Argentina
[9] Fdn FICMAC, Bogota, Colombia
[10] AC Camargo Canc Ctr, Sao Paulo, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
NSCLC; EGFR; Exon20; insertion;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-61
引用
收藏
页码：S666 / S666
页数：1
相关论文
共 50 条
  • [41] Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancer
    Gao, Xin
    Wei, Xue-Wu
    Zheng, Ming-Ying
    Chen, Zhi-Hong
    Zhang, Xu-Chao
    Zhong, Wen-Zhao
    Yang, Jin-Ji
    Wu, Yi-Long
    Zhou, Qing
    JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 5822 - +
  • [42] EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
    Leal, Jose Luis
    Alexander, Marliese
    Itchins, Malinda
    Wright, Gavin M.
    Kao, Steven
    Hughes, Brett G. M.
    Pavlakis, Nick
    Clarke, Stephen
    Gill, Anthony J.
    Ainsworth, Hannah
    Solomon, Benjamin
    John, Thomas
    CLINICAL LUNG CANCER, 2021, 22 (06) : E859 - E869
  • [43] Efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer harboring ERBB2 exon 20 insertions and non-ERBB2 exon 20 insertions
    Tu, Hai-Yan
    Kai Yin
    Ke, E-E
    Wu, Si-Pei
    Zhao, Xiaotian
    Li, Yang-Si
    Zheng, Mei-Mei
    Liu, Si-Yang Maggie
    Sun, Yue-Li
    Lin, Jia-Xin
    Bai, Xiao-Yan
    Zhang, Yi-Chen
    Qing Zhou
    Yang, Jin-Ji
    Zhong, Wenzhao
    Wang, Bin-Chao
    Zhu, Dongqin
    Yang, Lingling
    Ou, Qiuxiang
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes
    Chouaid, Christos
    Filleron, Thomas
    Debieuvre, Didier
    Perol, Maurice
    Girard, Nicolas
    Dansin, Eric
    Lena, Herve
    Gervais, Radj
    Cousin, Sophie
    Otto, Josiane
    Schott, Roland
    Planchard, David
    Madroszyk, Anne
    Kaderbhai, Coureche
    Dubray-Longeras, Pascale
    Hiret, Sandrine
    Pichon, Eric
    Clement-Duchene, Christelle
    Chenuc, Gaelle
    Simon, Gaetane
    Bosquet, Lise
    QUantin, Xavier
    TARGETED ONCOLOGY, 2021, 16 (06) : 801 - 811
  • [45] A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes
    Christos Chouaid
    Thomas Filleron
    Didier Debieuvre
    Maurice Pérol
    Nicolas Girard
    Eric Dansin
    Hervé Lena
    Radj Gervais
    Sophie Cousin
    Josiane Otto
    Roland Schott
    David Planchard
    Anne Madroszyk
    Courèche Kaderbhai
    Pascale DUBRAY-Longeras
    Sandrine Hiret
    Eric Pichon
    Christelle Clément-Duchêne
    Gaëlle Chenuc
    Gaëtane Simon
    Lise Bosquet
    Xavier QUantin
    Targeted Oncology, 2021, 16 : 801 - 811
  • [46] Uncommon and Rare EGFR Mutations in Non-Small Cell Lung Cancer Patients with a Focus on Exon 20 Insertions and the Phase 3 PAPILLON Trial: The State of the Art
    Fabrizio, Federico Pio
    Attili, Ilaria
    de Marinis, Filippo
    CANCERS, 2024, 16 (07)
  • [47] The clinical outcomes of different first-line treatment strategies in advanced non-small cell lung cancer patients with EGFR exon 20 insertion mutation
    Ou, Wei-Fan
    Huang, Yen-Hsiang
    Hsu, Kuo-Hsuan
    Tseng, Jeng-Sen
    Lee, Po-Hsin
    Yang, Tsung-Ying
    RESPIROLOGY, 2023, 28 : 100 - 101
  • [48] PORTUGUESE CLINICAL PRACTICE IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER WITH EGFR EXON 20 INSERTION MUTATIONS
    Pinheiro, B.
    Carvalho, P.
    Silva Miguel, L.
    Rodrigues, A.
    Teixeira, E.
    Barata, F.
    da Luz, R.
    Hespanhol, V
    Lopes, R.
    Santos, S.
    Borges, M.
    VALUE IN HEALTH, 2022, 25 (12) : S286 - S286
  • [49] Clinical Differences of EGFR Mutations in Exon 19 and 21 in Clinical Course of Non-Small Cell Lung Cancer Patients
    Jang, Tae Won
    Jung, Maanhong
    Oak, Chul H.
    Nam, Sung J.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S528 - S528
  • [50] Survival and Clinical Immunotherapy Outcomes in Hispanic Patients vs Non-Hispanic White Patients with Non-Small Cell Lung Cancer
    Raez, L.
    Saravia, D.
    Sumarriva, D.
    Ruiz, R.
    Izquierdo, P.
    Cress, D.
    Hunis, B.
    Mas, L.
    Lopes, G.
    Kaen, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S871 - S871
12345